CLINICAL TRIALS PROFILE FOR CENESTIN
✉ Email this page to a colleague
All Clinical Trials for CENESTIN
Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
---|---|---|---|---|---|---|
NCT00272935 ↗ | A Clinical Trial to Demonstrate the Efficacy and Safety of Cenestin 0.3 mg for the Treatment of Hot Flashes | Completed | Duramed Research | Phase 3 | 2005-12-01 | This is a randomized, double-blind study to compare the efficacy and safety of daily doses of Cenestin 0.3 mg tablets to placebo in reducing the frequency and severity of moderate to severe hot flashes in postmenopausal women. |
>Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for CENESTIN
Condition Name
Clinical Trial Locations for CENESTIN
Trials by Country
Clinical Trial Progress for CENESTIN
Clinical Trial Phase
Clinical Trial Sponsors for CENESTIN
Sponsor Name